Skip to main content

Table 1

From: Levosimendan benefits critically ill patients with decompensated heart failure assessed with plasma B-type natriuretic peptide (BNP) and LVEF

n = 14

Pre-infusion

Post-infusion

% Change

P*

LVEF (%)

25 ± 3

31 ± 3

+31 ± 10

0.006

BNP (pg/ml)

859 ± 140

475 ± 111

-35 ± 11%

0.004

  1. Data presented as mean ± SE. * Wilcoxon Rank Sum.